Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Accumulated Depreciation (2020 - 2021)

Atea Pharmaceuticals has reported Accumulated Depreciation over the past 2 years, most recently at $161000.0 for Q4 2021.

  • Quarterly results put Accumulated Depreciation at $161000.0 for Q4 2021, up 21.97% from a year ago — trailing twelve months through Dec 2021 was $161000.0 (up 21.97% YoY), and the annual figure for FY2021 was $161000.0, up 21.97%.
  • Accumulated Depreciation for Q4 2021 was $161000.0 at Atea Pharmaceuticals, up from $132000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation for AVIR hit a ceiling of $161000.0 in Q4 2021 and a floor of $126000.0 in Q3 2020.